Home » Human Genome Working to Ensure Supply of Lupus Drug
Human Genome Working to Ensure Supply of Lupus Drug
Human Genome Sciences Inc. shocked Wall Street last year with the clinical success
of its experimental lupus treatment; now, the company wants to make sure there are no surprises in providing an adequate supply upon regulatory approval,
which could come later this year.
Capital
Capital
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May